Chemours (CC)

Cost of Revenue

$4.91B

TTM · Period ending: · USD

CC logo

CC Cost of Revenue

Latest reported$4.91B
CC TTM Cost of Revenue ($5.07B → $4.91B)
High-resolution chart · PNG

CC cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Chemours Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
4,908,000,000
4,940,000,000
4,906,000,000
4,850,000,000
4,805,000,000
4,714,000,000
4,660,000,000
4,696,000,000
4,695,000,000
4,682,000,000
4,772,000,000
4,751,000,000
4,882,000,000
5,067,000,000
5,177,000,000
5,223,000,000
5,131,000,000
5,104,000,000
4,965,000,000
4,808,000,000
4,531,000,000
4,034,000,000
3,902,000,000
4,080,000,000
4,200,000,000
4,391,000,000
4,464,000,000
4,325,000,000
4,380,000,000
4,554,000,000
4,667,000,000
4,691,000,000
4,657,000,000
4,545,000,000
4,431,000,000
4,366,000,000
4,305,000,000
4,274,000,000
4,290,000,000
4,414,000,000
4,580,000,000
4,746,000,000
4,762,000,000
4,863,000,000
4,914,000,000
4,943,000,000
5,072,000,000
5,124,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.